Stay updated with breaking news from Nobreath Fe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UK, med-tech company, Bedfont Scientific Ltd., is celebrating a brighter 2022 as the U.S. Food and Drug Administration (FDA) cleared its NObreath FeNO monitor for use in monitoring airway inflammation.
Bedfont Scientific’s NObreath FeNO monitor has been cleared by the US Food and Drug Administration (FDA).
Bedfont's NObreath monitor for airway inflammation has been cleared for sale in the USA MAIDSTONE, England, Jan. 31, 2022 /PRNewswire/ -- UK, med-tech company, Bedfont Scientific Ltd.,